Literature DB >> 5662484

Production of glycoprotein by Candida albicans in a synthetic medium and its influence on the growth of newborn mice.

Z T Mankowski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5662484     DOI: 10.1007/BF02051419

Source DB:  PubMed          Journal:  Mycopathol Mycol Appl        ISSN: 0027-5530


× No keyword cloud information.
  7 in total

1.  The experimental pathogenicity of various species of Candida in Swiss mice.

Authors:  Z T MANKOWSKI
Journal:  Trans N Y Acad Sci       Date:  1957-04

2.  Physiological bases of morphogenesis in fungi. V. Effect of selenite and tellurite on cellular division of yeastlike fungi.

Authors:  G FALCONE; W J NICKERSON; W A TABER
Journal:  Can J Microbiol       Date:  1956-10       Impact factor: 2.419

3.  A colorimetric method for the determination of glucosamine and chondrosamine.

Authors:  L A Elson; W T Morgan
Journal:  Biochem J       Date:  1933       Impact factor: 3.857

4.  A study of conditions for Kjeldahl determination of nitrogen in proteins; description of methods with mercury as catalyst, and titrimetric and gasometric measurements of the ammonia formed.

Authors:  A HILLER; J PLAZIN; D D VAN SLYKE
Journal:  J Biol Chem       Date:  1948-12       Impact factor: 5.157

5.  Hemolysin from the yeast-like phases of some pathogenic fungi.

Authors:  S B SALVIN
Journal:  Proc Soc Exp Biol Med       Date:  1951-04

6.  The use of a precipitin test to differentiate Candida albicans from Candida stellatoidea.

Authors:  J R TRIMBLE
Journal:  J Invest Dermatol       Date:  1957-05       Impact factor: 8.551

7.  Quantitative Determination of Carbohydrates With Dreywood's Anthrone Reagent.

Authors:  D L Morris
Journal:  Science       Date:  1948-03-05       Impact factor: 47.728

  7 in total
  12 in total

1.  Clinical isolates of yeast produce a gliotoxin-like substance.

Authors:  D T Shah; B Larsen
Journal:  Mycopathologia       Date:  1991-12       Impact factor: 2.574

2.  Increased carbohydrate content in the thymus and spleen in mice receiving Candida albicans orally (occurrence of lymphomas).

Authors:  Z T Mankowski
Journal:  Mycopathol Mycol Appl       Date:  1972-08-07

3.  Growth stimulation and inhibition of Candida albicans by metabolic by-products.

Authors:  C G Saltarelli
Journal:  Mycopathol Mycol Appl       Date:  1973-09-28

4.  Occurrence of lymphomas and lupus erythematosus-like syndrome in the course of experimental Candida albicans infection in mice.

Authors:  Z T Mankowski
Journal:  Mycopathol Mycol Appl       Date:  1972-06-15

5.  Influence of Candida albicans glycoprotein on 3-methylcholanthrene induced malignancy in newborn rodents.

Authors:  Z T Mankowski
Journal:  Mycopathol Mycol Appl       Date:  1971-05-03

6.  Seizure induction by pentylenetetrazol in rodents receiving Candida albicans glycoprotein orally.

Authors:  Z T Mankowski
Journal:  Mycopathol Mycol Appl       Date:  1971-10-13

7.  Chemotherapy of experimental endogenous Candida albicans endophthalmitis.

Authors:  D B Jones
Journal:  Trans Am Ophthalmol Soc       Date:  1980

8.  Fungal toxins as a parasitic factor responsible for the establishment of fungal infections.

Authors:  K Iwata
Journal:  Mycopathologia       Date:  1978-12-18       Impact factor: 2.574

9.  Pathological changes in the thymus in the course of experimental chronic Candida albicans infection in mice.

Authors:  Z T Mankowski
Journal:  Mycopathol Mycol Appl       Date:  1968-12-31

10.  Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infections.

Authors:  M G Shepherd
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.